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CASE REPORT
Long-term survival without recurrence 
after surgery for gastric yolk sac tumor-like 
carcinoma: a case report
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Abstract 
Background: Gastric yolk sac tumor (YST)-like carcinoma is extremely rare, and its prognosis is poor, because most 
patients have widespread metastases at the time of diagnosis. We report a case of gastric YST-like carcinoma with an 
adenocarcinoma component without metastases in which curative resection was performed.
Case presentation: A 77-year-old man complaining of melena and dizziness due to anemia was diagnosed with 
poorly differentiated adenocarcinoma in the gastric cardia, with a benign ulcer in the gastric body. He underwent 
total gastrectomy with D2 lymph node dissection for the tumor. Histological examination of the resected speci-
mens revealed a mixture of reticular and glandular neoplastic components morphologically. In the reticular area, an 
endodermal sinus pattern and some Schiller–Duval bodies were confirmed. Gastric YST-like carcinoma with adeno-
carcinoma components, T2N0M0 Stage IB, was diagnosed. Immunohistochemical analysis showed that the YST was 
positive for carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP) and p53. In contrast, the adenocarcinoma was 
positive for p53 and negative for CEA and AFP. The patient remained healthy as of 7 years postoperatively, with no 
recurrence.
Conclusions: Routine medical examinations or endoscopic examinations for accidental symptom may be helpful for 
early diagnosis and good prognosis for gastric YST-like carcinoma, although the prognosis is generally poor.
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Background
Yolk sac tumors (YSTs) are germ cell tumors, which usu-
ally arise in the gonads, but can also occur in extrago-
nadal regions such as the sacrococcygeal region, the 
lungs, the anterior mediastinum, the retroperitoneum, 
and the brain. These tumors have also been reported to 
arise as a component in carcinomas with heterogeneous 
differentiation in the lungs, stomach, large intestine, gall-
bladder, pancreas, urinary bladder, and so on [1]. Gastric 
YST-like carcinoma is extremely rare, and only 19 cases 
have been reported [1–19]. Generally, gastric YST-like 
carcinoma is a highly aggressive tumor with a poor prog-
nosis, because most patients display lymph node or dis-
tant metastases at the time of diagnosis.
Here, we present a case of gastric YST with adenocar-
cinoma components that was curatively resected, obtain-
ing long-term survival without recurrence for the patient.
Case presentation
A 77-year-old man visited a previous hospital complain-
ing of melena and dizziness due to anemia. Endoscopic 
examination showed an ulcerated tumor at the gastric 
cardia, clinically suspected to represent gastric cancer 
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(Fig. 1a, b), and an ulcer at the mid-body of the stomach 
causing active bleeding (Fig. 1c). Biopsy was performed, 
and histological features of the specimen from the cardia 
were interpreted as a poorly differentiated adenocarci-
noma, while the specimen from the mid-body was a non-
neoplastic lesion. The patient was referred to our hospital. 
Computed tomography (CT) of the abdomen and pelvis 
did not show any thickening of the stomach wall indi-
cating the tumor, and no lymph node enlargement was 
found (Fig.  1d). Serum levels of carcinoembryonic anti-
gen (CEA) and carbohydrate antigen 19-9 (CA19-9) 
were normal. Blood analysis for serum alpha-fetoprotein 
(AFP) was not performed preoperatively. The patient 
underwent total gastrectomy with D2 lymph node dis-
section followed by Roux-en-Y esophagojejunostomy and 
cholecystectomy (Fig. 2a). Histopathological examination 
of the resected specimens revealed the presence of two 
microscopic patterns: an adenocarcinoma component; 
and a YST component (Fig. 2b). The tumor mostly com-
prised various areas of differentiated tubular adenocarci-
noma. However, a YST component was seen as a lace-like 
(reticular) network lined by cuboidal to flattened malig-
nant cells and papillary structures (Fig.  2c). Schiller–
Duval bodies were also sporadically present (Fig. 2d). The 
tumor had invaded the muscularis propria, but no lymph 
nodes metastasis was confirmed, and T2N0M0 Stage IB 
was diagnosed according to the Japanese classification of 
gastric carcinoma [20]. Immunohistochemical analysis 
showed that most of the YST component was positive for 
AFP, CEA and p53. The adenocarcinoma component was 
Fig. 1 a Esophagogastroduodenoscopy shows an ulcerated tumor at the gastric cardia. b Narrow-band imaging of tumor shows irregular 
microvascular and microsurface patterns with wavy micro-vessels. c Esophagogastroduodenoscopy also shows an ulcer with exposed vessel at 
the mid-body of the stomach. d Computed tomography of the abdomen and pelvis shows no thickening of the stomach wall and no lymph node 
enlargement
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positive for p53, but negative for AFP and CEA (Fig. 3). 
After the surgery, serum AFP level remained normal. The 
patient remains healthy and without tumor recurrence as 
of 7 years postoperatively.
Discussion
Gastric germ cell tumors are extremely rare; choriocarci-
noma arising in the stomach has been reported to com-
prise less than 0.1% of all gastric cancers and YST-like 
carcinoma is much rarer than choriocarcinoma [1]. The 
origin of YST arising in the stomach remains unclear. The 
main hypothesis is that YST derives from migrating germ 
cells during embryogenesis, similar to other extragonadal 
germ cell tumors [6]. This hypothesis is based on the 
fact that some pure YST-like carcinomas in the stomach 
have been reported [4, 9, 11–13, 18, 19]. However, sev-
eral reports have suggested that adenocarcinoma com-
ponents of the tumor heterogeneously transform to YST 
through aberrant differentiation, because the majority of 
gastric YST-like carcinomas are accompanied by an ade-
nocarcinoma component, as observed in the current case 
[1, 2, 12]. Moreover, Puglisi et al. [6] confirmed identical 
p53 mutations in both adenocarcinoma and YST in the 
stomach using molecular analysis, which may support 
the hypothesis that adenocarcinoma components hetero-
geneously transform to YST. We did not perform a brain 
CT and an ultrasound examination of testes to exclude 
other primary lesions of germ cell tumor. We diagnosed 
the present case as a primary gastric YST-like carcinoma, 
because this tumor accompanied with adenocarcinoma 
component.
Histologically, YST exhibits the feature of an endoder-
mal sinus tumor, including reticular, microcystic, polyve-
sicular, papillary, solid, or tubercular patterns [19]. The 
most characteristic finding is Schiller–Duval bodies, as 
glomerulus-like structures that were also detected in the 
current case. YST cells often contain hyaline droplets that 
stain positive for Periodic acid-Schiff. Serum AFP levels 
Fig. 2 a Resected specimens show Borrman type 3 tumor in the cardia (arrowheads). b–d Histological examination reveals an adenocarcinoma 
component and a yolk sac tumor (YST) component, with a reticular pattern (c) and Schiller–Duval bodies (d) are observed in YST component 
(hematoxylin and eosin staining)
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generally increase, and the cells stain positively for AFP 
immunohistochemically, because the YST cells produce 
AFP. AFP-producing gastric carcinomas are rare, report-
edly representing about 1.2% of all gastric carcinomas 
[5]. Hepatoid adenocarcinoma is the most common AFP-
producing gastric carcinoma. Hepatoid adenocarcinoma 
shows several pathological overlaps with YST, as both 
glandular and hepatocellular differentiation with AFP 
production. Schiller–Duval bodies are a salient compo-
nent distinguishing YST from hepatoid adenocarcinoma.
Twenty cases of gastric YST-like carcinoma, including 
the current case, have been reported in the medical lit-
erature and are summarized in Table  1. This pathology 
usually affects middle-aged and elderly men and 13 cases 
(65%) have also been reported to show adenocarcinoma 
components. It is difficult to expect gastric YST-like car-
cinoma endoscopically, because there are no characteris-
tic findings in gastric YST-like carcinoma. In the current 
case, irregular microvascular and microsurface patterns 
with wavy micro-vessels were observed in narrow-band 
Fig. 3 Immunohistochemical staining of the tumor shows the yolk sac tumor (YST) component is positive for alpha-fetoprotein (AFP), 
carcinoembryonic antigen (CEA) and p53. The adenocarcinoma (AC) component is positive for p53, but negative for AFP and CEA
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imaging of endoscopic examination (Fig. 1b), which were 
characteristic findings of poorly differentiated adeno-
carcinoma of stomach. YST components were immu-
nohistochemically positive for AFP in all cases, but the 
adenocarcinoma component was generally negative, as 
confirmed by the current case. Serum AFP levels were 
increased in the most cases. Serum AFP level is useful in 
the diagnosis and surveillance of gastric YST-like carci-
noma, but was only measured after surgery in the present 
case, because we did not measure routinely serum AFP 
for gastric cancer before surgery, and did not elevate at 
any point. The prognosis of patients with gastric YST-
like carcinoma is generally poor, because most patients 
have widespread metastases at the time of diagnosis, and 
most patients die within 1 year after diagnosis. We did 
not perform adjuvant chemotherapy for the present case 
according to Japanese gastric cancer treatment guidelines 
[21]. Although adjuvant chemotherapies including cispl-
atin, vinblastine, bleomycin, and etoposide according to 
germ cell tumor treatment were performed for advanced 
gastric YST-like carcinoma, they have not been shown 
improve long-term survival [5–7, 13]. The chemotherapy 
regimens for common type gastric cancer consists of ade-
nocarcinoma might be recommended if it was hypothe-
sized that adenocarcinoma components heterogeneously 
transform to YST. In the current case, gastric YST-like 
carcinoma could be detected without metastasis due to 
occasional bleeding from a gastric benign ulcer concur-
rent with gastric YST-like carcinoma although the patient 
had not undergone endoscopic examination before YST-
like carcinoma was detected.
Conclusions
A routine or endoscopic examination for accidental 
symptom may be helpful for achieving early diagnosis 
and good prognosis for gastric YST-like carcinoma, even 
though the prognosis is generally poor.
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Table 1 Summary of gastric yolk sac tumor-like carcinomas in the literature
YST yolk sac tumor, AC adenocarcinoma, CC choriocarcinoma, HC hepatocellular carcinoma, LN lymph node, S surgery, CT chemotherapy, NM not mentioned
Authors (year) Age/Sex Histology Metastasis Therapy Prognosis
Garcia (1985) 65/M YST, CC, AC Liver None Autopsy case
Motoyama (1985) 72/F YST, AC LN S Alive (3 years)
Zamecnik (1993) 88/M YST LN, Peritoneum S Died (4 weeks)
Suzuki (1999) 56/M YST, AC LN S, CT Died (6 months)
Puglisi (1999) 61/M YST, AC Peritoneum Palliative S Died (1 months)
Wang (2000) 36/M YST, AC LN CT Died (6 months)
Napaki (2004) 38/F YST, AC Liver CT, S Alive (32 months)
Kanai (2005) 87/M YST None S Died (7 months)
Singh (2007) 67/M YST, AC Liver, LN S, CT Died (2 months)
Tahara (2008) 74/M YST Liver, Lung, LN None Died (6 days)
Kim (2009) 61/M YST None S Alive (3 months)
Magni (2010) 62/M YST LN S, CT Died (1 year)
(2011) 74/M YST, CC, AC Liver, LN S, RFA, CT Alive (8 months)
Bihari (2013) 50/M YST, AC Liver None NM
Yalaza (2017) 68/F YST, AC LN S, CT Died (8 months)
Lakshmanan (2017) 75/M YST, AC, HC None S Alive (30 months)
Qureshi (2018) 52/M YST, AC LN S, CT Alive (16 months)
Mandelia (2018) 3/M YST Liver, Peritoneum CT, S Alive (5 months)
Ibrahim (2019) 86/F YST None S NM
Present case 77/M YST, AC None S Alive (7 years)
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